Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices
- 23 February 2021
- journal article
- research article
- Published by Anticancer Research USA Inc. in In Vivo
- Vol. 35 (2), 1163-1168
- https://doi.org/10.21873/invivo.12364
Abstract
Background/Aim: This study aimed to assess the association of the modified albumin-bilirubin (mALBI) grade with the endoscopic findings of gastroesophageal varices (GEVs). Patients and Methods: A total of 141 patients with histologically proven cirrhosis who underwent a liver biopsy and esophagogastroduodenoscopy were enrolled. The relationships between the mALBI grade and endoscopic findings were evaluated. Results: The incidence of GEVs and high-risk GEVs differed among mALBI grades. Patients with mALBI grades of 2b-3 had higher rates of GEVs and high-risk GEVs in comparison to those with mALBI grades of 1-2a (p<0.0001). In addition, patients with mALBI grade 2b or grade 3, but not those with mALBI grade 2a, had significantly higher rates of complicated GEVs and high-risk GEVs in comparison to those with mALBI grade 1. Conclusion: The mALBI grade may be useful in predicting the presence of GEVs and for stratifying their bleeding risk.Keywords
This publication has 18 references indexed in Scilit:
- Prediction of the varices needing treatment with non‐invasive tests in patients with compensated advanced chronic liver diseaseLiver International, 2018
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJournal of Hepatology, 2018
- Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter AnalysisLiver Cancer, 2018
- EASL Clinical Practice Guidelines: Management of alcohol-related liver diseaseJournal of Hepatology, 2018
- The noninvasive diagnosis of esophageal varices and its application in clinical practiceClinics and Research in Hepatology and Gastroenterology, 2018
- Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varicesGastrointestinal Endoscopy, 2018
- Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseasesHepatology, 2016
- Evidence-based clinical practice guidelines for liver cirrhosis 2015The Esophagus, 2016
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015